PLIN2 and cancer: According to the Genomics of Drug Sensitivity in Cancer (GDSC) and Cancer Therapeutics Response Portal (CTRP) databases, we selected the top four drugs negatively correlated with PLIN2, namely Z-LLNle-CHO, tozasertib, dabrafenib and CIL55 (Fig. 9a,b).